Interview with Sheneskin CEO Yuri Balkhanov on Novoskin technology and clinical experience.

Key points from the article: cell cultures are used as “factories” for proteins and growth factors; the finished dressing contains no living cells — ensuring sterility and long-term stability; application protocol: apply to a prepared wound for up to 10 days; epithelialization usually begins by days 5–7; clinical cases: faster closure of burns and chronic ulcers, reduced pain; in some cases skin grafting can be avoided; logistics: storage for up to 12 months at +2…+8 °C, no incubators — an advantage over foreign cell-based analogues; development: scaling production and expanding indications.